Vesicular stomatitis virus–based vaccines against lassa and ebola viruses

Andrea Marzi, Friederike Feldmann, Thomas Geisbert, Heinz Feldmann, David Safronetz

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalEmerging Infectious Diseases
Volume21
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Lassa virus
Ebolavirus
Vesicular Stomatitis
Vaccines
Viruses
Ebola Vaccines
Vaccination
Immunity

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology

Cite this

Vesicular stomatitis virus–based vaccines against lassa and ebola viruses. / Marzi, Andrea; Feldmann, Friederike; Geisbert, Thomas; Feldmann, Heinz; Safronetz, David.

In: Emerging Infectious Diseases, Vol. 21, No. 2, 2015, p. 305-307.

Research output: Contribution to journalArticle

Marzi, Andrea ; Feldmann, Friederike ; Geisbert, Thomas ; Feldmann, Heinz ; Safronetz, David. / Vesicular stomatitis virus–based vaccines against lassa and ebola viruses. In: Emerging Infectious Diseases. 2015 ; Vol. 21, No. 2. pp. 305-307.
@article{8500905a03394ba5a7a34f06fa631cda,
title = "Vesicular stomatitis virus–based vaccines against lassa and ebola viruses",
abstract = "We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.",
author = "Andrea Marzi and Friederike Feldmann and Thomas Geisbert and Heinz Feldmann and David Safronetz",
year = "2015",
doi = "10.3201/eid2102.141649",
language = "English (US)",
volume = "21",
pages = "305--307",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "2",

}

TY - JOUR

T1 - Vesicular stomatitis virus–based vaccines against lassa and ebola viruses

AU - Marzi, Andrea

AU - Feldmann, Friederike

AU - Geisbert, Thomas

AU - Feldmann, Heinz

AU - Safronetz, David

PY - 2015

Y1 - 2015

N2 - We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.

AB - We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.

UR - http://www.scopus.com/inward/record.url?scp=84921818775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921818775&partnerID=8YFLogxK

U2 - 10.3201/eid2102.141649

DO - 10.3201/eid2102.141649

M3 - Article

C2 - 25625358

AN - SCOPUS:84921818775

VL - 21

SP - 305

EP - 307

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 2

ER -